Genzyme, Sanofi Take Aim At Generic Cancer Drug
Drugmakers Genzyme and Sanofi-Aventis sued three pharmaceutical companies Friday in Delaware federal court, claiming that the companies' generic drugs will violate Genzyme's patents for the cancer treatment drug Mobozil....To view the full article, register now.
Already a subscriber? Click here to view full article